Research & development

Infant Bacterial Therapeutics' most advanced clinical program is the IBP-9414 project developing a preventive treatment against necrotizing enterocolitis (NEC) and improvement of so-called feeding tolerance in premature infants.
Read more


FEBRUARY 11, 2020
Year-end report 2019, 08.00 CET

MARCH 3, 2020
Carnegie Nordic Healthcare Seminar, Stockholm

WEEK 14, 2020
Annual Report 2019
Read More